Retrospective Analysis of Skin Toxicity in Patients under Anti-EGFR Tyrosine Kinase Inhibitors: Our Experience in Lung Cancer

BACKGROUND: Tyrosine kinase inhibitors (TKIs) have been introduced for the treatment of lung cancer, improving progression-free survival, objective response rate, and quality of life. However, TKIs can lead to cutaneous toxicities, including papulopustular rash, xerosis, paronychia with/without pyog...

Descripción completa

Detalles Bibliográficos
Autores principales: Annunziata, Maria Carmela, Ferrillo, Maria, Cinelli, Eleonora, Panariello, Luigia, Rocco, Danilo, Fabbrocini, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Republic of Macedonia 2019
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454160/
https://www.ncbi.nlm.nih.gov/pubmed/30976343
http://dx.doi.org/10.3889/oamjms.2019.170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454160/
https://www.ncbi.nlm.nih.gov/pubmed/30976343
http://dx.doi.org/10.3889/oamjms.2019.170

Ejemplares similares